Fig. 1 · Structure

Documents & Downloads

Miltefosine

Cat. No. A14138 CAS 58066-85-6

PI3K/Akt inhibitor

Miltefosine inhibits PI3K/Akt activity with ED50 of 17.2 μM and 8.1 μM in carcinoma cell lines A431 and HeLa

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
Akt N/A
PI3K
PKC ~7 μM

Cellular Effect

Cell Line Activity Value Description Reference
786-0 IC50 > 100 μM Cytotoxicity against human 786-O cells assessed as decrease in mitochondrial viability after 6 hrs by CMXRos staining based assay [PMID: 29407968]
A2780 IC50 8.87 μM Cytotoxicity against human A2780 cells after 24 hrs by MTT method [PMID: 25698517]
A-431 IC50 12 μM Cytotoxic activity against human A431 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay [PMID: 25814031]
A-431 IC50 53.7 μM Cytotoxicity against human A431 cells after 24 hrs by MTT assay [PMID: 20039643]
A549 IC50 > 100 μM Cytotoxicity against human A549 cells after 48 hrs by CellTiter-Glo assay [PMID: 29407968]
A549 IC50 44.7 μM Cytotoxicity against human A549 cells after 72 hrs by MTT assay [PMID: 19762125]
A549 IC50 8.5 μM Cytotoxic activity against human A549 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay [PMID: 25814031]
A549 IC50 8.6 μM Cytotoxicity against human A549 cells after 72 hrs by MTT assay [PMID: 23792315]
A549 IC50 9.6 μM Inhibition of Akt phosphorylation in insulin-stimulated human A549 cells treated 2 hrs before insulin stimulation measured after 30 mins by ELISA [PMID: 22138309]
A549 IC50 9.6 μM Inhibition of Akt phosphorylation in human insulin-stimulated A549 cells incubated for 2 hrs prior to insulin-induction measured after 30 mins by ELISA [PMID: 23415083]
A549 IC50 9.7 μM Cytotoxicity against human A549 cells after 24 hrs by FACS analysis [PMID: 22138309]
A549 IC50 9.7 μM Cytotoxicity against human A549 cells by flow cytometric analysis [PMID: 23415083]
BJ IC50 > 50 μM Cytotoxicity against human BJ cells after 24 hrs by redox-sensitive dye based fluorescent assay [PMID: 33091607]
BMDM IC50 ≥ 200 μM Cytotoxicity against mouse BMDM after 96 hrs by MTT assay [PMID: 23719286]
CCRF-CEM IC50 13.5 μM Cytotoxicity against human CCRF-CEM cells after 72 hrs by MTT assay [PMID: 19762125]
CCRF-CEM IC50 20.7 μM Cytotoxicity against human CCRF-CEM cells after 72 hrs by MTT assay [PMID: 23792315]
DU-145 IC50 24.92 μM In vitro cytotoxic activity against prostate carcinoma (DU-145) cells assayed by inhibition of [3H]-labeled thymidine incorporation [PMID: 11728191]
DU-145 IC50 25.78 μM Antiproliferative activity against human DU145 cells assessed as inhibition of cell proliferation incubated for 18 hrs followed by MTT addition for 4 hrs by MTT assay [PMID: 25128666]
Erythrocyte EC50 30 μM Toxicity in human erythrocytes assessed as hemolysis after 1 hr [PMID: 19762125]
HeLa IC50 16.5 μM Cytotoxic activity against human HeLa cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay [PMID: 25814031]

20 records · Scroll to view more

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 58066-85-6
Applications PI3K/Akt inhibitor
Formula C21H46NO4P
Molecular Weight 407.6
Synonyms HePC
SMILES
CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO Insoluble
Water 77 mg/mL (188.92 mM)
Ethanol 77 mg/mL (188.92 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

In Vivo Preparation

Concentration
28 mg/mL
Vehicle
Saline

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...